Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Ogunniyi, 2006
Cohort:
Indianapolis-Ibadan Dementia Project - Indianapolis Cohort
Risk Factor:
Alcohol
Average Follow-up Time Detail
Follow-up time was not presented in the article; was presented in the cited article describing the cohorts (Hendrie, et al., JAMA, 2001).
Ethnicity Detail
Participants were African-Americans from Indianapolis.
Age Detail
This is the mean age of 1,255 study participants who completed the screening; 498 of the them were clinically assessed and included in this analysis, but the baseline age for this subset was not reported.
Screening and Diagnosis Detail
Screening Method:
CSID
Community Screening Interview for Dementia
AD Diagnosis:
NINCDS ADRDA
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
"Essentially, a two-stage designwas utilized comprising the administration of the Community-Screening Instrument for Dementia (CSI’D) to eligible participants. The incidence study was conducted in two waves – two and five years after the prevalence study. Sub-samples of the study participants were selected for clinical assessment according to established cut-off scores that were derived from discriminant function analysis. Details of these had been described (Hall et al., 1996). The clinical assessment included a structured interview with an informant, neuropsychological testing, and examination by a physician as well as laboratory and imaging studies. All the information obtained was utilized in the consensus diagnosis process within each site, and inter-site agreement was essential before the final diagnoses were recorded. The Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-IIIR) and International Classification of Diseases, 10th Revision (ICD-10) criteria were used to diagnose dementia (American Psychiatric Association, 1987; World Health Organization, 1992). For AD, the National Institute for Neurological and Communicative Diseases and Stroke – Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria were used (McKhann et al., 1984)."
Covariates & Analysis Detail
Analysis Type:
Logistic regression
AD Covariates:
A
age
G
gender